Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
AbCellera logo — Our platform integrates biology, computation, and engineerin...

AbCellera

Our platform integrates biology, computation, and engineering to develop impactful antibody-based medicines.

Founded 2012 Canada Canada 588 employees

General Information

Company Name AbCellera
Founded Year 2012
Location Canada Canada
Employees 588
Business Model B2B, Platform, API
Revenue Model Licensing, Performance Based, Project Based
Social

BounceWatch is an independent company data service, not affiliated with AbCellera. To contact AbCellera, visit abcellera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AbCellera compare?

A PDF of AbCellera and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AbCellera soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Nov 05, 2026

AbCellera will present at the UBS Global Biopharma Conference on November 17, 2026.

AbCellera a competitor of yours? Have our desk watch it

About AbCellera

AbCellera, founded in 2012 and headquartered in Canada, is a clinical-stage biotechnology company making significant strides in the field of antibody-based therapeutics. The company operates at the confluence of biology, computation, and engineering, living up to its slogan: "Our platform integrates biology, computation, and engineering to develop impactful antibody-based medicines."

Focused on sectors including endocrinology, women’s health, immunology, and oncology, AbCellera leverages its robust platform to discover and develop innovative medicines. Despite successfully advancing into multiple therapeutic areas, information on the company's latest investments or investors remains unavailable, potentially indicating a focus on internal development strategy. As a pivotal player within the biotechnology landscape, AbCellera represents a compelling opportunity for investors keen on investing in transformative healthcare solutions.

Business keywords: Antibody Discovery, Clinical-stage Biotechnology, Endocrinology Medicines, Women's Health Medicines, Immunology Medicines, Oncology Medicines, Monoclonal Antibody Discovery, Cell Culture, Protein Analysis, Microfluidic Single Cell Analysis, Single Cell Genomics, Cell Enrichment, Cell Screening, Protein Engineering, Bispecific T Cell Engagers

Services & Products

Antibody-based Medicine Development
Clinical Trials Management
Drug Discovery and Development
Biological Computation
GPCR and Ion Channel Technologies

Target Customers

Pharmaceutical Companies Biotech Firms Medical Research Institutions

No funding data available for AbCellera yet.

AbCellera Alternatives & Competitors

AbCellera vs
Alector
Alector United States

We are on a mission to make brain disorders history.

IPO
141 employees
Biotechnology, Health Care

FAQ About AbCellera

Our platform integrates biology, computation, and engineering to develop impactful antibody-based medicines.
AbCellera was founded in 2012.
AbCellera is headquartered in Canada.
AbCellera has a B2B, Platform and API business model. Its revenue comes from Licensing, Performance Based and Project Based.
AbCellera has approximately 588 employees.
AbCellera offers: Antibody-based Medicine Development, Clinical Trials Management, Drug Discovery and Development, Biological Computation, GPCR and Ion Channel Technologies.
Top alternatives and competitors to AbCellera include Alector. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AbCellera and Alector are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AbCellera, https://www.bouncewatch.com/company/abcellera, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout